See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Alzheimer's Benefits Continue With Donanemab for 3 Years, Long-Term Data Show

Summary by MedPage Today
Experts also present appropriate use recommendations

2 Articles

MedPage TodayMedPage Today
Reposted by
Anti-Aging, Acupuncture and Health NewsAnti-Aging, Acupuncture and Health News
Center

Alzheimer's Benefits Continue With Donanemab for 3 Years, Long-Term Data Show

Experts also present appropriate use recommendations

·New York, United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

MedPage Today broke the news in New York, United States on Friday, August 1, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Alzheimer's Disease icon

Alzheimer's Disease

Toronto, ON icon

Toronto, ON

News
For You
SearchBlindspotLocal